<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>out-of-pocket payment &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/out-of-pocket-payment/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Oct 2026 08:00:48 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>out-of-pocket payment &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Immune Therapy&#8217;s Hidden Cost: Nearly Three in Ten Lung Cancer Patients Face Severe Financial Toxicity</title>
		<link>https://bioengineer.org/immune-therapys-hidden-cost-nearly-three-in-ten-lung-cancer-patients-face-severe-financial-toxicity/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 08:00:48 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[financial navigation]]></category>
		<category><![CDATA[financial toxicity]]></category>
		<category><![CDATA[health economics]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[latent profile analysis]]></category>
		<category><![CDATA[lung cancer]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[out-of-pocket payment]]></category>
		<category><![CDATA[Patient-reported outcomes]]></category>
		<category><![CDATA[psychological resilience]]></category>
		<category><![CDATA[Social support]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=425150</guid>

					<description><![CDATA[A latent profile analysis of 331 lung cancer patients receiving immunotherapy identified three distinct financial toxicity groups, with lower income, out-of-pocket payment, unemployment, low social support and low resilience linked to the most severe distress.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">425150</post-id>	</item>
	</channel>
</rss>
